D'hondt Catheleyne, Ponsaerts Raf, Srinivas Sangly P, Vereecke Johan, Himpens Bernard
Laboratory of Physiology, KULeuven, Leuven, Belgium.
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):120-33. doi: 10.1167/iovs.06-0770.
Thrombin, a serine protease, breaks down the barrier integrity of corneal endothelial cells by phosphorylation of the regulatory light chain of myosin II (myosin light chain; MLC), which induces contractility of the actin cytoskeleton. This study was undertaken to investigate the effect of thrombin on gap junctional (GJIC) and paracrine (PIC) intercellular communication in cultured bovine corneal endothelial cells (BCECs).
An intercellular Ca(2+) wave, a form of cell-cell communication, was elicited by applying a mechanical stimulus to a single cell in a confluent monolayer. Changes in Ca(2+) were imaged by fluorescence microscopy with a fluorescent calcium indicator, and the images were used to calculate the area reached by the Ca(2+) wave (active area). GJIC was assessed by fluorescence recovery after photobleaching (FRAP). Activity of hemichannels was assayed by lucifer yellow (LY) uptake and also by adenosine triphosphate (ATP) release by using the luciferin-luciferase technique.
RT-PCR showed transcripts for PAR-1 and -2 receptors, but not for PAR-4 receptors. Immunocytochemistry showed thrombin-sensitive PAR receptors as well as trypsin-sensitive PAR-2 receptors. Both thrombin and the selective PAR-1 agonist TRAP-6 reduced the active area of the Ca(2+) wave. These agents also reduced the fluorescence recovery in FRAP experiments. The effect of thrombin on the Ca(2+) wave was inhibited by a peptide antagonist of PAR-1, but not by a PAR-4 antagonist. Pretreatment with ML-7 (an MLCK inhibitor), Y-27632 (a Rho kinase inhibitor) or chelerythrine (a PKC inhibitor) prevented the effect of thrombin on the Ca(2+) wave. Activation of PAR-1 did not affect the Ca(2+) wave propagation in cells pretreated with Gap26, which blocks hemichannels. However, PAR-1 activation decreased the active area in cells pretreated with Gap27, which inhibits gap junctions. Thrombin abolished enhancement of the Ca(2+) wave propagation by ARL-67156 (inhibitor of ecto-ATPases). The effect of the PAR-1 agonists on the Ca(2+) wave was not detectable in cells pretreated with exogenous apyrases.
Thrombin inhibits intercellular Ca(2+) wave propagation in BCECs. This effect is due to activation of PAR-1 receptors and involves MLC phosphorylation by MLCK-, PKC- and Rho kinase-sensitive pathways. Thrombin mainly inhibits the ATP-mediated PIC pathway, and also reduces GJIC to a lesser extent.
凝血酶是一种丝氨酸蛋白酶,通过使肌球蛋白 II 的调节轻链(肌球蛋白轻链;MLC)磷酸化来破坏角膜内皮细胞的屏障完整性,从而诱导肌动蛋白细胞骨架的收缩性。本研究旨在探讨凝血酶对培养的牛角膜内皮细胞(BCECs)中缝隙连接(GJIC)和旁分泌(PIC)细胞间通讯的影响。
通过对汇合单层中的单个细胞施加机械刺激来引发细胞间 Ca(2+) 波,这是一种细胞间通讯形式。使用荧光钙指示剂通过荧光显微镜对 Ca(2+) 的变化进行成像,并使用这些图像计算 Ca(2+) 波到达的面积(活性面积)。通过光漂白后荧光恢复(FRAP)评估 GJIC。通过荧光素黄(LY)摄取以及使用荧光素 - 荧光素酶技术检测三磷酸腺苷(ATP)释放来测定半通道活性。
RT-PCR 显示 PAR-1 和 -2 受体有转录本,但 PAR-4 受体没有。免疫细胞化学显示凝血酶敏感的 PAR 受体以及胰蛋白酶敏感的 PAR-2 受体。凝血酶和选择性 PAR-1 激动剂 TRAP-6 均降低了 Ca(2+) 波的活性面积。这些试剂在 FRAP 实验中也降低了荧光恢复。PAR-1 的肽拮抗剂可抑制凝血酶对 Ca(2+) 波的作用,但 PAR-4 拮抗剂则不能。用 ML-7(一种 MLCK 抑制剂)、Y-27632(一种 Rho 激酶抑制剂)或白屈菜红碱(一种 PKC 抑制剂)预处理可防止凝血酶对 Ca(2+) 波的作用。PAR-1 的激活在经 Gap26 预处理的细胞中不影响 Ca(2+) 波的传播,Gap26 可阻断半通道。然而,PAR-1 的激活在经 Gap27 预处理的细胞中降低了活性面积,Gap27 可抑制缝隙连接。凝血酶消除了 ARL-67156(胞外 ATP 酶抑制剂)对 Ca(2+) 波传播的增强作用。在经外源性腺苷三磷酸双磷酸酶预处理的细胞中未检测到 PAR-1 激动剂对 Ca(2+) 波的作用。
凝血酶抑制 BCECs 中的细胞间 Ca(2+) 波传播。这种作用是由于 PAR-1 受体的激活,并且涉及由 MLCK、PKC 和 Rho 激酶敏感途径介导的 MLC 磷酸化。凝血酶主要抑制 ATP 介导的 PIC 途径,并且在较小程度上也降低 GJIC。